Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bayer : Shareholder Temasek Agrees to Increase Share Capital

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2018 | 07:29am CEST

By Anthony Shevlin

Bayer said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company.

Temasek has subscribed to 31 million new Bayer shares, which equals around 3.6 percent of Bayer's capital stock, for 3 billion euros ($3.71 billion) in total gross proceeds, Bayer said.

Under the agreement, Bayer will issue the new registered--no par value--shares to a subsidiary of Temasek at market prices with an entitlement to dividends as of Jan. 1, 2017, the German company said.

Once the capital increase has been completed, and together with its existing shareholdings, Temasek will hold approximately 4 percent of Bayer's issued capital stock, Bayer said. The issued shares won't be subject to any lock-up period, it said.

Bayer Chief Executive Werner Baumann said the "investment affirms our business strategy including the proposed acquisition of Monsanto], as well as Bayer's strong growth prospects."

Write to Anthony Shevlin at [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
MONSANTO 0.32% 125 Delayed Quote.7.04%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20MONSANTO : Russian nod moves Bayer closer to wrapping up Monsanto deal
RE
04/20BAYER : Gains Russian Approval for Monsanto Deal
DJ
04/20BAYER : Temasek subscribes to capital increase and acquires approximately 3.6 pe..
AQ
04/20RUSSIA GIVES GREEN LIGHT TO BAYER'S : Ifax
RE
04/18BAYER AKTIENGESELLSCHAFT : Release according to Article 41 of the WpHG [the Germ..
EQ
04/18BAYER : commits to provide innovative vector control solutions to help eradicate..
PU
04/17EASTON PHARMACEUTICALS : Announces BAYER Agreement Update
AQ
04/17BAYER : Shareholder Temasek to Increase Share Capital -- Update
DJ
04/17BAYER : Temasek subscribes to capital increase and acquires approximately 3.6 pe..
AQ
More news
News from SeekingAlpha
04/20Bayer wins Russian approval for Monsanto deal 
04/17Germany to go forward with plans to restrict Monsanto weedkiller 
04/17Bayer's ILDR2 inhibitor shows encouraging action in preclinical studies, disc.. 
04/17The U.S. Approves Bayer And Monsanto's Merger 
04/12VERASTEM : A Solid Player On A Crowded Field 
Financials (€)
Sales 2018 35 542 M
EBIT 2018 7 319 M
Net income 2018 4 811 M
Debt 2018 6 823 M
Yield 2018 2,85%
P/E ratio 2018 17,87
P/E ratio 2019 15,58
EV / Sales 2018 2,50x
EV / Sales 2019 2,33x
Capitalization 81 868 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 118 €
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-4.81%100 586
JOHNSON & JOHNSON-8.71%339 783
PFIZER0.86%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571